In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci
- 1 November 1997
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 29 (3) , 203-205
- https://doi.org/10.1016/s0732-8893(97)81811-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot modelAntimicrobial Agents and Chemotherapy, 1995
- The challenge of vancomycin-resistant enterococci: A clinical and epidemiologic studyAmerican Journal of Infection Control, 1995
- Chloramphenicol for the Treatment of Vancomycin-Resistant Enterococcal InfectionsClinical Infectious Diseases, 1995
- In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and EnterococciDiagnostic Microbiology and Infectious Disease, 1995
- Pristinamycin for Enterococcus faecium resistant to vancomycin and gentamicinThe Lancet, 1992
- Resistance of Enterococcus faecium to vancomycin and gentamicinThe Lancet, 1991
- In vitro comparison of ampicillin-chloramphenicol and ampicillin-cefotaxime against 284 Haemophilus isolatesAntimicrobial Agents and Chemotherapy, 1986
- Chloramphenicol kills Haemophilus influenzae more rapidly than does ampicillin or cefamandoleAntimicrobial Agents and Chemotherapy, 1983
- Chloramphenicol inhibition of the bactericidal effect of ampicillin against Haemophilus influenzaeAntimicrobial Agents and Chemotherapy, 1982